CESI held its conference discussing issues and solutions around housing and standard of living in Central Coast.
Cal Lutheran School of Management held a recruiting event in Vienna, Linz, and Graz for the EMBA in Austria program. Hub101 ...
On Monday, Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and Takeda Pharmaceutical Co Ltd (NYSE:TAK) released topline results for the Phase 3 VERIFY study of rusfertide for polycythemia vera.
Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...
January 30, 2025 Drugmaker Takeda's CEO Weber to step down, raises profit forecast Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm ...
Alice Gibbs is a Newsweek Senior Internet Trends & Culture Reporter based in the U.K. For the last two years she has specialized in viral trends and internet news, with a particular focus on ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...
Visit a quote page and your recently viewed tickers will be displayed here.
3382.T Seven & i Holdings Co., Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results